BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

BXPHARMA

All Eps Dividend Board Agm Q1 Q2 Q3

BXPHARMA 29-Jan-2018

(Q2 Un-audited): EPS was Tk. 1.66 for October-December, 2017 as against Tk. 1.47 for October-December, 2016; EPS was Tk. 3.25 for July-December, 2017 as against Tk. 2.74 for July-December, 2016. NOCFPS was Tk. 3.14 for July-December, 2017 as against Tk. 2.56 for July-December, 2016. NAV per share was Tk. 63.77 as on December 31, 2017 and Tk. 59.07 as on December 31, 2016.

BXPHARMA 22-Jan-2018

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 29, 2018 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2017. Post Date: 2018-01-22

BXPHARMA 18-Jan-2018

The Company has informed that it has disbursed the cash dividend for the year ended on June 30, 2017 to the respective shareholders' Bank Accounts through BEFTN system.

BXPHARMA 15-Nov-2017

Trading of the shares of the Company will resume on 16.11.2017 after record date.

BXPHARMA 14-Nov-2017

Trading of the shares of the Company will remain suspended on record date i.e., 15.11.2017.

BXPHARMA 13-Nov-2017

(Q1 Un-audited): EPS was Tk. 1.59 for July-September, 2017 as against Tk. 1.27 for July-September, 2016; NOCFPS was Tk. 1.56 for July-September, 2017 as against Tk. 1.62 for July-September, 2016. NAV per share was Tk. 63.36 as on September 30, 2017 and Tk. 60.97 as on September 30, 2016.

BXPHARMA 12-Nov-2017

Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 13.11.2017 to 14.11.2017. Trading of the shares of the Company will remain suspended on record date i.e., 15.11.2017.

BXPHARMA 07-Nov-2017

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2017 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2017.

BXPHARMA 26-Oct-2017

There will be no price limit on the trading of the shares of the Company today (26.10.2017) following its corporate declaration.

BXPHARMA 26-Oct-2017

(Continuation news of BXPHARMA): The Company has also reported EPS of Tk. 5.49, NAV per share of Tk. 61.82 and NOCFPS of Tk. 6.49 for the year ended on June 30, 2017 whereas EPS of Tk. 7.27 and NOCFPS of Tk. 8.21 for the 18 months period from January 01, 2015 to June 30, 2016. NAV per share was Tk. 59.70 as on June 30, 2016. (end)

Previous Next page